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affecting the physician prescribing decision included safety (96%),
efﬁcacy (90%), and cost (86%) of drug choice while the patients
viewed that efﬁcacy (86%), convenient dosage (53%), and safety
(42%) of a drug were their main concerns. About eight out of ten
patients reported that the sources of information for pain man-
agement were from specialists, friends/family, GPs and TV/Radio.
Nevertheless, most patients were not proactively discussing the
potential risks associated with prescription of NSAIDs with their
doctors. CONCLUSIONS: Different concerns and information
communicated by doctors may affect how it is perceived by
patients. Effective patient education is essential to encourage a
two-way communication between physician-patient to minimize
the negative outcomes and maximize the quality of care.
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OBJECTIVES: Health-related quality of life (HRQL) and its
impact upon productivity have not been well documented among
hemophilia patients, nor among their caregivers. This study of
hemophilia patients with inhibitors assessed patient and family
caregiver productivity and the impact of patient HRQL.
METHODS: Inhibitor patients who participated in a patient
forum were mailed a survey including questions on clinical and
demographic characteristics, aspects of medical care, HRQL (via
the SF-12 v2), and productivity. 53 of 90 surveys were returned.
Regression analyses assessed the association of patient and treat-
ment factors with HRQL mean physical (PCS) and mental (MCS)
composite summary scores and patient and caregiver productivity
(missed and low productivity days in the past year). RESULTS:
Patient mean age was 20.7 years (SD = 18.8), 88.5% were type A,
and 39.6% received on-demand therapy as their only treatment
mode. On-demand treatment (B = -0.336, P < 0.05) and number
of hemorrhages (B = -0.366, P < 0.05) were negatively associated
with PCS; and PCS was associated with patients’ missed work/
school days (IRR = 0.93, P < 0.001) and perceived impact on
daily activities (OR = 0.72, P < 0.05). PCS (IRR = 0.94, P < 0.01),
hemorrhages (IRR = 1.05, P < 0.05), surgery (IRR = 2.74,
P < 0.05), and younger age (IRR = 0.91, P < 0.01)were associated
with patients’ low productivity days. Patient surgery was associ-
ated with more caregiver missed days (IRR = 3.70, P < 0.05) and
more caregiver low productivity days (IRR = 8.99, P < 0.001).
Patient MCS was also associated with caregiver low productivity
days (IRR = 0.96, P < 0.01). CONCLUSIONS: Physical aspects
of HRQL among hemophilia patients with inhibitors impact their
daily activities and productivity; mental aspects of HRQL affected
the productivity of family caregivers.
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OBJECTIVES: Using the French national database of hospital
admissions in 2006, we estimated the economic burden for hos-
pitals of immune thrombocytopenic purpura (ITP) and ITP-
related splenectomy. METHODS: In France, public and private
hospital admissions are recorded in comprehensive administra-
tive databases that generate Diagnosis Related Groups (DRGs)
used for billing purposes, ICD10 diagnosis, and procedures
codes. Admissions for ITP were extracted. Admissions for ITP-
related splenectomy were identiﬁed by analyzing the surgical
procedures. Linking of each hospital stay and patient was made
to estimate the cost of ITP per patient. Admission costs from the
health care perspective were estimated from the 2007 ofﬁcial
DRG tariffs. RESULTS: In 2006, 10 561 hospital admissions for
ITP were recorded, of which 10,047 (95%) were in public or not
for proﬁt hospitals. In the public sector, 37 hospitals (i.e. 10% of
all public health care facilities) managed 50% of the caseload.
There were 269 admissions for ITP-related splenectomy, mainly
in the public sector (91%). Altogether 3612 patients in the public
sector required 9360 admissions or 2.80 in-patient admissions
per patient per year. In the private sector, 150 patients required
508 stays (3.4 hospital stays/patient/year). Based on these results,
the mean charge was €3653 per patient in public hospitals, and
€3177 per patient in private hospitals. The mean charge per
patient in public hospitals for ITP-related splenectomy was
€6367. These costs did not include expensive drugs, in particular
immunoglobulins or rituximab, which are excluded from the
DRGs reimbursement scheme in France and can result in extra
billing. CONCLUSIONS: Administrative databases allow the
estimation of the burden of ITP for hospitals. ITP and ITP-
related splenectomy were managed mostly in the public sector.
Splenectomy increased the cost per patient twofold. The cost of
expensive drugs to treat ITP must be evaluated in a separate
study.
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OBJECTIVES: Prior literature has suggested that the B domain
of FVIII may play a role in the rate of FVIII inactivation (Krenov
2006). Faster inactivation of recombinant B domain-deleted
factor VIII (BDD-rFVIII) could affect efﬁcacy during prophy-
laxis, potentially leading to increased risk for breakthrough
bleeds and higher FVIII utilization. The objective of this analysis
was to use real world data to determine whether patients treated
with BDD-rFVIII had higher annual FVIII utilization than
matched patients treated with full-length rFVIII (FL-rFVIII).
METHODS: Retrospective analysis of a large, US specialty phar-
macy database was conducted using 2006/2007 data. Patients
who were not receiving Immune Tolerance Therapy, had at least
six months of prescription activity, and did not switch brands
or treatment regimens were selected. BDD-rFVIII patients were
matched with up to 5 FL-rFVIII patients based on treatment
regimen (on-demand and prophylaxis), hemophilia severity and
age. The annualized number of international units (IU) dispensed
per kilogram was compared between both rFVIII groups using a
Wilcoxon Matched Pairs Test. Subgroup analysis was performed
by treatment regimen. RESULTS: Twenty-two BDD-rFVIII
patients met the inclusion criteria and were matched to 104
FL-rFVIII patients. Median annual IU/kg consumed for all BDD-
rFVIII and FL-rFVIII patients was 3630 and 3054 respectively
(p = 0.20). Subgroup analysis showed a statistically signiﬁcant
difference observed when comparing patients on a prophylactic
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treatment regimen. Here, BDD-rFVIII patients consumed a
median of 6204 IU/kg per year while matched FL-rFVIII patients
utilized a median of 4118 IU/kg (p = 0.03). This difference could
not be attributed to a higher prescribed prophylaxis dose. CON-
CLUSIONS: This analysis shows that BDD-rFVIII-treated
patients were associated with utilizing more IU/kg/year of FVIII
while on a prophylactic regimen than matched FL-rFVIII-treated
patients. Further research is required to determine whether
greater utilization of BDD-rFVIII during prophylaxis is associ-
ated with increased risk of breakthrough bleeds.
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OBJECTIVES: The objective of this study was to examine the
age-speciﬁc relationship between body mass index (BMI), preva-
lence of metabolic disorders, and utilization of outpatient ser-
vices. METHODS: Data for this study came from the National
Health Interview Survey in Taiwan, which was conducted in
2001. With the consent of the respondents, the interview data
were linked to their claims in the National Health Insurance
database. The self-reported weight and height were used to cal-
culated BMI. Diseases and utilization of outpatient services were
identiﬁed from the claims data. RESULTS: A linear trend of
prevalence was observed with increments of BMI. The same
trend was observed for the number of visits to outpatient clinics.
The BMI-related medical expenditures did not reach statistical
signiﬁcance. Nevertheless, age was an important factor. After
controlling for the number of chronic diseases, the relationship
between BMI and utilization of outpatient services disappeared.
CONCLUSIONS: The BMI-related medical expenditures per-
tained to metabolic disorders, such as hypertension, diabetes,
and ischemic heart diseases. A health promotion program should
prevent the diseases, thus reducing medical expenditures.
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OBJECTIVES: To contrast the factors that are associated with
metabolic syndrome risk for US adolescents overall and US His-
panic adolescents. METHODS: At risk is deﬁned as having three
or more of the following: elevated fasting glucose, elevated SBP,
elevated DBP, elevated triglycerides, elevated BMI, elevated waist
circumference, or low HDL. Logistic regression and NHANES
2003–2006 data were used to examine the impact on metabolic
syndrome risks; gender, race, ethnicity, immigrant status, income,
insurance, parental education, activity levels, number of school
lunches and breakfasts per week, milk consumption, language
preference, and number of meals outside the home per week. US
adolescents overall are compared with US Hispanic adolescents.
A signiﬁcance level of 0.05 was used. Weighted sample sizes for
Hispanic adolescents and US born adolescents are 8,178,714 and
50,837,204 respectively. RESULTS: The results of the regressions
were vastly different between US adolescents and US Hispanic
(First Generation and Native) adolescents. All variables in the
models are signiﬁcant. Major differences include the decreased
risk (42%) for US adolescent females overall, and the increased
risk (17%) for US Hispanic females. Notably, for those Hispanics
that are ﬁrst generation, their risk is increased by 65%. For US
adolescents overall, low or middle income levels increase risk
three times, while low and middle income level US Hispanic
adolescents have a risk decrease of 77% and 69% respectively.
For every meal eaten outside the home per week (excluding
school meals) the risk increases for US adolescents by 4% and by
13% for Hispanic US adolescents. CONCLUSIONS: These ado-
lescents are at risk for acute cardiovascular endpoints, higher
medical utilization and expenditure, and lower quality of life.
Interventions should focus on education regarding healthy eating
outside the home with limited resources. A surprising result of
this analysis is the high price of acculturation for Hispanic ﬁrst
generation adolescents.
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OBJECTIVES: To estimate the incremental costs following bari-
atric surgery, with regard to antidepressant use. METHODS:
Data was collected for body weight, mental health status such as
depression, medication use and counselling for one hundred sub-
jects pre and post bariatric surgery from 2006–2007. Measures
of mental health were compared before and after surgery. Cost
estimates for the management of depression were based on data
published in 2000. RESULTS: Patients lost a mean value of 52%
of their excess body weight. Following surgery, the proportion
of depressed patients decreased by 46%, the proportion of the
patients on antidepressants decreased by 30%, and the propor-
tion of those who utilized counselling services decreased by 19%.
When applying cost estimates for managing depression, total
incremental savings in depression management were $6,527
(average per patient per year estimate). CONCLUSIONS: Bari-
atric surgery is a costly procedure estimated at $22,213 per
procedure. Results from a Western New York center based on
100 patients suggest that reduction in depression and the asso-
ciated medication and counselling use provide incremental
savings of $6527 (per year) for the patients who have the pro-
cedure. In addition, co-morbidities associated with obese patients
such as diabetes, hypertension, sleep apnea, and venous insufﬁ-
ciency offer further incremental savings which is likely to offset
the cost of the bariatric surgery, possibly leading to savings.
Long-term outcomes of bariatric surgery and the associated
incremental cost were not evaluated in this study. Future research
should consider long-term outcomes and associated costs from
the societal, payer and patient perspectives. Maintaining the
weight loss over the long-term is likely to lead to signiﬁcant cost
savings from all perspectives and improved quality of life.
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OBJECTIVES: On October 26, 2005, Arkansas Medicaid imple-
mented a preferred drug list (PDL) policy for long acting narcotic
analgesics (LANA) where only generic long-acting morphine and
methadone could be obtained without prior-approval. The objec-
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